Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Cancer Medicine
|
August 19, 2025
Relative Dose Intensity of Trabectedin and Outcome of Advanced L-Sarcomas
Stephen Poitureau, Marie-Cécile Le Deley, Mehdi Brahmi, et al.
BMJ Open
|
April 23, 2022
Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study
Gisele Chvetzoff, Magali Girodet, Johanna Despax, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2020
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment
Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
November 9, 2024
Connecting the changing trace elements spectrum and survival in sarcoma: a pilot study
Laetitia Collet, Philippe Telouk, Francis Albarede, et al.
Cancers
|
July 29, 2023
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment
Xiaolan Feng, Laurie Tonon, Haocheng Li, et al.
Cancers
|
September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
Mehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
Cancers
|
July 20, 2021
<i>TP53</i> Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials
Elise F Nassif, Edouard Auclin, Rastilav Bahleda, et al.
The Oncologist
|
March 27, 2023
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection
Benoît Allignet, Paul Pou, Floriane Izarn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2019
A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma
Perrine Marec-Berard, Cécile Dalban, Nathalie Gaspar, et al.
JCO Precision Oncology
|
September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium
Antonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Cancer Medicine
|
August 19, 2025
Relative Dose Intensity of Trabectedin and Outcome of Advanced L-Sarcomas
Stephen Poitureau, Marie-Cécile Le Deley, Mehdi Brahmi, et al.
BMJ Open
|
April 23, 2022
Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study
Gisele Chvetzoff, Magali Girodet, Johanna Despax, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2020
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment
Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
November 9, 2024
Connecting the changing trace elements spectrum and survival in sarcoma: a pilot study
Laetitia Collet, Philippe Telouk, Francis Albarede, et al.
Cancers
|
July 29, 2023
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment
Xiaolan Feng, Laurie Tonon, Haocheng Li, et al.
Cancers
|
September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
Mehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
Cancers
|
July 20, 2021
<i>TP53</i> Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials
Elise F Nassif, Edouard Auclin, Rastilav Bahleda, et al.
The Oncologist
|
March 27, 2023
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection
Benoît Allignet, Paul Pou, Floriane Izarn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2019
A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma
Perrine Marec-Berard, Cécile Dalban, Nathalie Gaspar, et al.
JCO Precision Oncology
|
September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium
Antonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Page
of 8